Chronix Biomedical
San Jose, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HU
Howard UrnovitzFounder
JD
John DiPietroExecutive
Board
WB
William Boeger IIIBoard director
RL
Robert LeppoBoard director
PF
Paul FreimanBoard director
WM
William MitchellBoard director
DM
David MacKenzieBoard director
MJ
Michael JerstadBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.2M disclosed across 4 rounds · 2012–2017
▶$3.3MraisedJul 2017 · 40 investors · BiotechnologyRule 506(b)
▶$3.3MraisedJul 2017 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William MitchellDirector
- Michael JerstadDirector
- William Boeger IIIDirector
- David MacKenzieDirector
- Ekkehard SchuetzExecutive Officer
- Robert LeppoDirector
- John DiPietroExecutive Officer
- Howard B UrnovitzExecutive Officer, Director
- Paul FreimanDirector
- Offering amount
- $8M
- Amount sold
- $3.3M
- Minimum investment
- $2K
- Proceeds to insiders
- $250K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2017 · 25 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard B UrnovitzExecutive Officer, Director
- William MitchellDirector
- Michael JerstadDirector
- Robert LeppoDirector
- David MacKenzieDirector
- Paul FreimanDirector
- William Boeger IIIDirector
- John DiPietroExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.5M
- Minimum investment
- $2K
- Proceeds to insiders
- $100K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2016 · 25 investors · BiotechnologyRule 506(b)
▶$5MraisedOct 2016 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul FreimanDirector
- William Boeger IIIDirector
- William MitchellDirector
- Howard UrnovitzExecutive Officer, Director
- David MacKenzieDirector
- John DiPietroExecutive Officer
- Robert LeppoDirector
- Michael JerstadDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedApr 2014 · 26 investors · BiotechnologyRule 506(b)
▶$3.4MraisedApr 2014 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John DiPietroExecutive Officer
- David MacKenzieDirector
- Michael JerstadDirector
- Howard UrnovitzExecutive Officer, Director
- William Boeger IIIDirector
- William MitchellDirector
- Robert LeppoDirector
- Paul FreimanDirector
- Offering amount
- $14.5M
- Amount sold
- $3.4M
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Dec 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Chronix Biomedical?
- Chronix Biomedical was founded by Howard Urnovitz.
- Who are Chronix Biomedical's investors?
- Chronix Biomedical's investors include Boston Harbor Angels.
- How much funding has Chronix Biomedical raised?
- Chronix Biomedical has disclosed $13.2M raised across 4 rounds.
- Where is Chronix Biomedical headquartered?
- Chronix Biomedical is headquartered in San Jose, US.